Latest News & Updates

Breaking News

  • 4 hours ago

  • Simantini Singh Deo

Oncolytics Biotech® Strengthens Leadership Team With John McAdory As EVP And Yujun Wu As Head Of Biostatistics
Breaking News
Clearmind Medicine Reports Successful Completion Of Treatment For Second Cohort In Phase I/IIa CMND-100 Trial

Simantini Singh Deo

Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife

Team Pharma Now

Praxis Precision Medicines Appoints Renowned Epilepsy Leader Dr. Orrin Devinsky As Head Of Clinical Strategy

Vaibhavi M.

Shuttle Pharma Applauds Utah’s AI Prescription Pilot, Highlights Molecule.ai Vision; Program Signals A New Era For Healthcare And Drug Discovery

Vaibhavi M.

Other trending news you may like to read

Oncolytics Biotech® Strengthens Leadership Team With John McAdory As EVP And Yujun Wu As Head Of Biostatistics

Oncolytics names John McAdory EVP Strategy and Yujun Wu VP Biostatistics to support late-stage oncology trials.

Simantini Singh Deo

Pharma Now

Clearmind Medicine Reports Successful Completion Of Treatment For Second Cohort In Phase I/IIa CMND-100 Trial

Clearmind completes treatment of all patients in the second cohort of its Phase I/IIa CMND-100 trial for AUD.

Simantini Singh Deo

Pharma Now

Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife

STEERLife supports BionPharma in achieving USFDA approval for generic Etravirine using continuous, solvent-free manufacturing.

Team Pharma Now

Pharma Now

Praxis Precision Medicines Appoints Renowned Epilepsy Leader Dr. Orrin Devinsky As Head Of Clinical Strategy

Renowned neurologist Orrin Devinsky joins Praxis to shape clinical strategy and advance precision CNS therapies.

Vaibhavi M.

Pharma Now